Pharmacokinetics of Low Molecular Weight [dalteparin] and Unfractionated Heparin in Pregnancy
Phase of Trial: Phase II
Latest Information Update: 07 Nov 2016
At a glance
- Drugs Dalteparin sodium (Primary) ; Heparin (Primary)
- Indications Pregnancy; Spontaneous abortion; Thrombosis
- Focus Pharmacokinetics
- 20 May 2016 Status changed from active, no longer recruiting to completed.
- 17 Feb 2009 Planned end date changed from 1 Mar 2010 to 1 Mar 2012 as reported by ClinicalTrials.gov.
- 15 Aug 2008 New trial record.